T0	Participants 158 188	children with acute diarrhoea.
T1	Participants 242 303	children with heavy economic burden for families and society.
T2	Participants 447 477	children with acute diarrhoea.
T3	Participants 548 590	children (age 3-36 m) with acute diarrhoea
T4	Participants 880 935	55 children in placebo group and 52 in synbiotic group.
T5	Participants 936 1009	The two groups were similar for demographic and clinical characteristics.